LONDON, March 25, 2014 /PRNewswire/ --
The trading session on Monday, March 24,
2014 ended on a lower note as the Dow Jones Industrial
Average finished at 16,276.69, down 0.16% and the NASDAQ Composite
closed at 4,226.39, down 1.18%. The S&P 500 finished the
session 0.49% lower at 1,857.44. The losses were broad based with
eight out of ten sectors ending the session in negative. The
S&P 500 Health Care Sector Index finished the day 1.41% lower
at 666.18, while the same has gained 4.41% in the last three
months. Investor-Edge has initiated coverage on the following
equities: St Jude Medical Inc. (NYSE: STJ), Stryker Corp. (NYSE:
SYK), Zimmer Holdings Inc. (NYSE: ZMH) and Edwards Lifesciences
Corp. (NYSE: EW). Free technical research on STJ, SYK, ZMH and EW
can be downloaded upon signing up at:
http://www.investor-edge.com/463-register
St Jude Medical Inc.'s shares recorded a trading volume of 1.92
million shares, as compared with a three months average volume of
2.48 million shares. The stock ended the day at $65.51, down 0.17% and recorded an intraday range
of $64.72 and $67.13. Shares of the company traded at a PE
ratio of 17.34. St Jude Medical Inc.'s shares have lost 2.28% in
the previous three trading sessions and 3.26% in the last one
month, while the shares have gained 5.75% on YTD basis. The
company's stock is trading above its 50-day and 200-day moving
averages of $65.26 and $56.72, respectively. Furthermore, the stock is
trading at an Relative Strength Index of 46.55. Sign up today to
read free research on STJ at:
http://www.investor-edge.com/463-STJ-24Mar2014.pdf
On Monday, shares in Stryker Corp. recorded a trading volume of
2.16 million shares, as compared with a three months average volume
of 1.62 million shares. The stock ended the day at $79.31, down 1.92% and at an intraday range of
$79.18 and $81.25. Shares of the company traded at a PE
ratio of 18.92. Stryker Corp.'s shares have fallen by 2.35% in the
previous three trading sessions and 3.99% in the last one month,
while the shares have advanced 5.55% on YTD basis. The company's
shares are trading below their 50-day moving average. Stryker
Corp.'s 50-day moving average of $79.86 is above the 200-day moving average of
$72.92. Further, the stock is trading
at an RSI of 50.47. Sign up today to read free research on SYK
at:
http://www.investor-edge.com/463-SYK-24Mar2014.pdf
Shares in Zimmer Holdings Inc. edged 1.58% lower on Monday,
finishing the day at $92.06. A total
of 1.34 million shares were traded, which is above the three months
average volume of 1.13 million. The company's shares oscillated
between $91.42 and $94.11 during the
session. The stock traded at a PE ratio of 16.02. Zimmer Holdings
Inc.'s shares have lost 2.82% in the previous three trading
sessions, 3.69% in the last one month and 1.21% on YTD basis. The
company's stock is trading below its 50-day moving average. Zimmer
Holdings Inc.'s 50-day moving average of $95.23 is above the 200-day moving average of
$87.18. Additionally, the stock is
trading at an RSI of 40.65. Sign up today to read free research on
ZMH at:
http://www.investor-edge.com/463-ZMH-24Mar2014.pdf
On Monday, Edwards Lifesciences Corp.'s stock declined 1.65%,
closing the day at $70.94. The stock
recorded trading volume of 1.15 million shares as compared to a
three months average volume of 1.27 million shares. The stock
fluctuated between $70.34 and $72.67
during the trading session. The stock traded at a PE ratio of
23.57. Edwards Lifesciences Corp.'s shares have declined 4.04% in
the previous three trading sessions, while the stock has advanced
2.96% in the last one month and 7.88% on YTD basis. The company's
stock is trading above its 50-day and 200-day moving averages of
$69.13 and $68.84, respectively. Moreover, the stock is
trading at an RSI of 56.50. Sign up today to read free research on
EW at:
http://www.investor-edge.com/463-EW-24Mar2014.pdf
===============
EDITOR'S NOTES:
===============
1. This is not company news. We are an independent source and our
views do not reflect the companies mentioned.
2. Information in this release is fact checked and produced on a
best efforts basis and reviewed by Nidhi Vatsal, a CFA
charterholder. However, we are only human and are prone to make
mistakes. If you notice any errors or omissions, please notify us
below.
3. This information is submitted as a net-positive to companies
mentioned, to increase awareness for mentioned companies to our
subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our
team, or wish to learn more about our services, please contact us
at pubco [at] www.investor-edge.com.
5. For any urgent concerns or inquiries, please contact us at
compliance [at] www.investor-edge.com.
6. Are you a public company? Would you like to see similar coverage
on your company? Send us a full investors' package to research [at]
www.investor-edge.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis.
This document, article or report is prepared and authored by
Investor-edge. An outsourced research services provider represented
by Nidhi Vatsal, CFA, has only reviewed the information provided by
Investor-edge in this article or report according to the Procedures
outlined by Investor-edge. Investor-edge is not entitled to veto or
interfere in the application of such procedures by the outsourced
provider to the articles, documents or reports, as the case may
be.
NOT FINANCIAL ADVICE
Investor-edge makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or
otherwise), of the information provided in this document. This
information is not to be construed as personal financial advice.
Readers are encouraged to consult their personal financial advisor
before making any decisions to buy, sell or hold any securities
mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Investor-edge is not responsible for any error which may be
occasioned at the time of printing of this document or any error,
mistake or shortcoming. No liability is accepted by Investor-edge
whatsoever for any direct, indirect or consequential loss arising
from the use of this document. Investor-edge expressly disclaims
any fiduciary responsibility or liability for any consequences,
financial or otherwise arising from any reliance placed on the
information in this document. Investor-edge does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the
information. The included information is subject to change without
notice.
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute.
SOURCE Investor-Edge